COVID patients can't get Paxlovid
The price is one reason Paxlovid is not reaching those who need it most
Salon ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
FORGOTTEN HISTORY: Chad worz - The Untold Story
Why covid patients who could most benefit from paxlovid still aren’t getting it
During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.
The Texas Tribune ·
Nursing homes still waiting for vaccines
"The United States has been phenomenal in screwing up vaccinations," one doctor said
Salon ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
Salon
The Texas Tribune
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
